{"schema_version":"secwatch.filing_event.v1","accession":"0001606498-23-000023","form_type":"8-K","ticker":"AVNS","cik":"0001606498","company_name":"AVANOS MEDICAL, INC.","filed_at":"2023-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.809662+00:00","generated_at":"2026-06-18T11:40:16.866935+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Avanos Medical appoints Dr. Lisa Egbuonu-Davis to board of directors","bullets":["Dr. Egbuonu-Davis appointed as independent director effective March 6, 2023; serves on Compliance and Governance Committees.","She receives $70,000 annual cash retainer, $7,500 Compliance Committee fee, $5,000 Governance Committee fee, and $190,000 in RSUs.","Board now comprises six directors: five independent, two women, one ethnically diverse.","Egbuonu-Davis is VP Medical Innovations at DH Diagnostics (Danaher affiliate); previously VP at Sanofi and roles at Pfizer."],"urls":{"canonical":"https://secwatch.observer/filing/0001606498-23-000023","json":"https://secwatch.observer/filing/0001606498-23-000023.json","markdown":"https://secwatch.observer/filing/0001606498-23-000023.md","text":"https://secwatch.observer/filing/0001606498-23-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000023/0001606498-23-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000023/avns-20230228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T11:40:16.866935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eee794d30b","claim":"Dr. Lisa Egbuonu-Davis was appointed as Director at AVANOS MEDICAL, INC..","evidence_excerpt":"On February 28, 2023, the Board of Directors (the “Board”) of Avanos Medical, Inc. (the “Company”) appointed Dr. Lisa Egbuonu-Davis to the Board, effective March 6, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000023/0001606498-23-000023-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}